Medication info
Candeplus Tablet

Candeplus Tablet

Prescription medicationTabletOral
Ingredient · strength
Candesartan Cilexetil›16mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Huons Co., Ltd.
Appearance
Biconvex, light pink, rectangular tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200904162 · Notified 2009.06.15 · Insurance code 670604580

Summary

Main use
Treatment of essential hypertension not controlled with a single ingredient
Who takes it
Adults
Adult dose
The recommended dose is 1 tablet once daily, taken with or without food. 1) Adults: The dose of candesartan cilexetil should first be adjusted before switching to this medicine. When clinically appropriate, direct switching from monotherapy to this medicine may be considered. The antihypertensive effect is usually achieved within 4 weeks of starting treatment. 2) Older adults: No dose adjustment of this medicine is necessary for older adults. 3) Patients with intravascular volume depletion: Dose adjustment of candesartan cilexetil is recommended in patients at risk of hypotension, such as those who may have reduced effective blood volume (the initial dose of candesartan cilexetil in these patients is 4 milligrams). 4) Patients with renal impairment: In patients with mild to moderate renal impairment and creatinine clearance of 30-80ml/min/1.73㎡ BSA, consider adjusting the dose of candesartan cilexetil before switching to this medicine (the initial dose of candesartan cilexetil in these patients is 4 milligrams). Do not administer to patients with severe renal impairment (creatinine clearance below 30ml/mim/1.73㎡ BSA). 5) Patients with hepatic impairment: It is recommended that the dose of candesartan cilexetil be adjusted before administering this medicine to patients with mild to moderate hepatic impairment (the initial dose of candesartan cilexetil in these patients is 2 milligrams). Do not administer to patients with severe hepatic impairment or cholestasis.

Ingredients

Manufacturer
Huons Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with a single ingredient

  • Essential hypertension
View approved original text

Essential hypertension generally presents challenges in controlling blood pressure, making it difficult to expect sufficient effects from individual component therapies alone. In such cases, effective management of blood pressure and reduction of the risk of cardiovascular complications can be achieved through combination therapies. Therefore, the treatment of essential hypertension requires a multifaceted approach, utilizing an appropriate combination of medications tailored to the patient's condition for stable blood pressure control. This medication is used for managing such hypertension.

How to take

Adult dose

The recommended dose is 1 tablet once daily, taken with or without food. 1) Adults: The dose of candesartan cilexetil should first be adjusted before switching to this medicine. When clinically appropriate, direct switching from monotherapy to this medicine may be considered. The antihypertensive effect is usually achieved within 4 weeks of starting treatment. 2) Older adults: No dose adjustment of this medicine is necessary for older adults. 3) Patients with intravascular volume depletion: Dose adjustment of candesartan cilexetil is recommended in patients at risk of hypotension, such as those who may have reduced effective blood volume (the initial dose of candesartan cilexetil in these patients is 4 milligrams). 4) Patients with renal impairment: In patients with mild to moderate renal impairment and creatinine clearance of 30-80ml/min/1.73㎡ BSA, consider adjusting the dose of candesartan cilexetil before switching to this medicine (the initial dose of candesartan cilexetil in these patients is 4 milligrams). Do not administer to patients with severe renal impairment (creatinine clearance below 30ml/mim/1.73㎡ BSA). 5) Patients with hepatic impairment: It is recommended that the dose of candesartan cilexetil be adjusted before administering this medicine to patients with mild to moderate hepatic impairment (the initial dose of candesartan cilexetil in these patients is 2 milligrams). Do not administer to patients with severe hepatic impairment or cholestasis.

Precautions

This medication can cause serious harm to the fetus and newborn, especially during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Individuals allergic to any of the ingredients in this medication or sulfonamide-based drugs, pregnant women or those planning to become pregnant, and women who are breastfeeding should not take this medication. Patients with severely impaired kidney function, seriously impaired liver function, a history of angioedema, gout, and certain electrolyte imbalances should also avoid this medication. Patients with excessively low blood pressure or problems with body fluid and electrolyte balance, liver disease patients, patients with heart valve disease, those with hyperkalemia, and the elderly should use this medication with caution, and should be closely monitored under a doctor's guidance. This medication may cause side effects such as headache, dizziness, fatigue, abdominal pain, nausea, and rare adverse reactions such as blood abnormalities, liver function abnormalities, skin rashes, and muscle pain. Reports have particularly noted an increased risk of skin cancer, so care should be taken to avoid excessive sun exposure, and immediate consultation with medical personnel is advised if any unusual skin indications occur. As this medication lowers blood pressure, when taken with other antihypertensive agents or diuretics, regular monitoring of blood pressure, kidney function, and electrolyte levels is necessary, and attention should be given to any occurrences of side effects. This medication should not be used during pregnancy or breastfeeding, and women of childbearing potential should consult a physician before use. The safety of this medication in children and adolescents has not been established, so it is advisable not to use this medication in those populations. In case of overdose, symptoms such as hypotension, dizziness, and electrolyte imbalances may occur, and immediate medical treatment should be sought. This medication should be kept out of reach of children, stored in its original container to prevent misuse or quality degradation. Caution is advised when driving or operating machinery as dizziness or fatigue may occur.

Side effects

  • headache
  • back pain
  • dizziness
  • respiratory tract infections
  • symptoms similar to influenza
  • sinusitis
  • bronchitis
  • urinary tract infections
  • nausea
  • contusion
Show 72 more
  • tachycardia
  • fatigue
  • abdominal pain
  • pharyngitis
  • heart block
  • vomiting
  • dyslipidemia
  • nasopharyngitis
  • cough
  • elevated blood sugar
  • increased serum uric acid
  • elevated ALT
  • decreased hemoglobin
  • increased serum AST
  • increased creatinine
  • elevated urea
  • increased potassium
  • decreased sodium
  • leukopenia
  • neutropenia
  • agranulocytosis
  • dizziness
  • intestinal vascular edema
  • diarrhea
  • renal failure
  • angioedema
  • rash
  • urticaria
  • pruritus
  • arthralgia
  • myalgia
  • hyperkalemia
  • hyponatremia
  • increased liver enzyme levels
  • abnormal liver function
  • hepatitis
  • deep vein thrombosis
  • neuropathy
  • blurred vision
  • choroidal exudate
  • acute myopia
  • acute closed-angle glaucoma
  • dyspnea
  • acute respiratory distress syndrome
  • anorexia
  • loss of appetite
  • gastrointestinal irritation
  • constipation
  • pancreatitis
  • interstitial nephritis
  • rash
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • erythema multiforme-like reaction
  • activation of erythema multiforme
  • muscle cramps
  • hyperglycemia
  • hyperuricemia
  • electrolyte imbalance
  • orthostatic hypotension
  • necrotizing vasculitis
  • weakness
  • fever
  • anaphylactic reaction
  • jaundice
  • sleep disturbances
  • depression
  • anxiety
  • edema
  • myalgia
  • hypercalcemia
  • dysuria

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air and moisture from entering, preferably at a cool temperature below 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness and prevent deterioration.

Appearance and packaging

Appearance

Biconvex, light pink, rectangular tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.